Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

Published Date: 15 Dec 2023

In the HHT trial, daily treatment for 24 weeks considerably decreased the frequency of recurrent nosebleeds.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

2.

Cancer mortality continuing to decline, says report

3.

Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?

4.

Stereotactic Radiation Linked to Better Brain Mets Outcomes

5.

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot